Streetbeat News

Equity Actions

DJT

Trump Media & Technology has entered into a registration rights agreement with WorldConnect IPTV Solutions and JedTec as part of an asset acquisition. As consideration, 5.1 million shares have been issued with registration rights granted under the Securities Act.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:30 pm

IFIN

INFINT Acquisition Corporation has delisted from the NYSE.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:18 pm

CTMX

CytomX Therapeutics has filed a $250 million mixed securities shelf with the SEC, allowing the company to issue various types of securities over time.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:11 pm

ITRM

Iterum Therapeutics shares are trading higher following the announcement that the company will receive $7.4M in gross proceeds from the expiration and results of its rights offering.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:42 pm

NWN

NW Natural Holdings has appointed Raymond Kaszuba as the new CFO, effective August 31, 2024. Kaszuba brings extensive experience from his previous roles at AmeriGas, UGI Corporation, and Enviva.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:38 pm

GNS

Genius Group shares are trading higher following the announcement that the company's board has approved the purchase of up to 10 million shares by founder and CEO Roger James Hamilton.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:37 pm

GNS

Genius Group Limited (NYSE:GNS) announced that its Founder & CEO, Roger James Hamilton, will purchase up to 10 million ordinary shares of the company. The shares will be bought at 105% of the closing price on the prior trading day, using a combination of cash and debt conversion. The purchase may occur in multiple tranches as approved by the NYSE.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:16 pm

CRNX

Crinetics Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 financial results. The company also announced the departure of its CFO, and Oppenheimer lowered its price target on the stock from $74 to $73.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:13 pm

MNMD

Mind Medicine shares are trading lower following the announcement of a $75 million public offering of common shares and pre-funded warrants.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 4:53 pm

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) reported its fourth-quarter financial results, showing $5.31 billion in revenue and $6.25 earnings per share, which missed analyst expectations. Despite a 110% year-over-year revenue increase driven by AI infrastructure demand, shares fell 5.5% over the trailing week. The company announced a 10-for-1 stock split effective Oct. 1 and provided strong guidance for fiscal 2025.

Portfolio Pulse from Henry Khederian

August 09, 2024 | 4:42 pm